Literature DB >> 30943735

Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial.

Vittorio Franciosi1, Giuseppe Maglietta2, Claudia Degli Esposti3, Giuseppe Caruso4, Luigi Cavanna5, Raffaella Bertè6, Gianpaolo Bacchini4, Letizia Bocchi4, Erico Piva7, Michela Monfredo5, Valentina Scafuri7, Pamela Di Cesare5, Barbara Melotti3, Manuel Sequino2, Anita Rimanti4, Cinzia Binovi4, Francesco Ghisoni8, Caterina Caminiti2.   

Abstract

BACKGROUND: To compare quality of life (QoL) of patients receiving early palliative care (EPC) vs. standard oncologic care (SOC).
METHODS: Pragmatic, multicenter, randomized trial at five University and Community Hospital Cancer Centers in Northern Italy. Advanced non-small cell lung, gastric, pancreatic and biliary tract cancer patients diagnosed within the previous 8 weeks. In the EPC arm, visits were performed systematically by a dedicated physician/nurse palliative care (PC) team, who assessed physical and psychosocial symptoms, and enacted the necessary services. In the SOC arm, PC visits were only carried out if requested. The primary outcome was the difference in the change of QoL [Functional Assessment of Cancer Therapy-General measure (FACT-G)] from baseline to 12 weeks in the two groups.
RESULTS: From November 2014 to March 2016, 281 patients were enrolled (142 EPC, 139 SOC); 218 completed FACT-G at 12 weeks. Baseline demographic and clinical characteristics were similar for the two groups. Values of FACT-G at baseline and 12 weeks were 72.3 (SD 12.6) and 70.1 (SD 15.5) for patients enrolled in the EPC arm, vs. 71.7 (SD 14.7) and 69.6 (SD 15.5) for the SOC arm, but the change scores did not differ significantly between groups. In the multivariable analysis, adjusting for QoL at baseline, two potential prospective prognostic factors were statistically significant: lung cancer (P=0.03) and interaction of living without a partner and intervention arm (P=0.01). Dying within 6 months (P<0.001) was also statistically significant.
CONCLUSIONS: In this study, EPC did not improve QoL in advanced cancer patients, but our findings highlight aspects which may guide future research on EPC.

Entities:  

Keywords:  Non-small-cell lung cancer; early palliative care (EPC); gastric cancer; pancreatic cancer; randomized clinical trial

Mesh:

Year:  2019        PMID: 30943735     DOI: 10.21037/apm.2019.02.07

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  8 in total

1.  Trends and outcomes of early and late palliative care consultation for adult patients with glioblastoma: A SEER-Medicare retrospective study.

Authors:  Adela Wu; Beatrice Ugiliweneza; Dengzhi Wang; Gary Hsin; Maxwell Boakye; Stephen Skirboll
Journal:  Neurooncol Pract       Date:  2022-03-30

Review 2.  Models of Integration of Specialized Palliative Care with Oncology.

Authors:  Jean Mathews; Breffni Hannon; Camilla Zimmermann
Journal:  Curr Treat Options Oncol       Date:  2021-04-08

3.  Application of the Six-Step Standard Communication Process in the Communication Training for Newly Recruited Nurses in Cancer Specialist Hospitals.

Authors:  Jingzhi Geng; Miao Liu; Huanhuan Zhang; Jian Gao; Li Wang; Yu Zhang; Fengyan Ma; Yan Liu
Journal:  Front Surg       Date:  2022-02-08

Review 4.  Timely Palliative Care: Personalizing the Process of Referral.

Authors:  David Hui; Yvonne Heung; Eduardo Bruera
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

5.  Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients.

Authors:  Vincent Chung; Virginia Sun; Nora Ruel; Thomas J Smith; Betty R Ferrell
Journal:  J Palliat Med       Date:  2021-10-26       Impact factor: 2.947

6.  Cancer patients in Palliative Care: occurrences related to venipuncture and hypodermoclysis.

Authors:  Fabiana Bolela; Roberta de Lima; Ana Carolina de Souza; Michele Rocha Moreira; Ana Julia de Oliveira Lago; Giovana Paula Rezende Simino; Jakeline Silva de Araújo
Journal:  Rev Lat Am Enfermagem       Date:  2022

7.  The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.

Authors:  Sabrina Bajwah; Adejoke O Oluyase; Deokhee Yi; Wei Gao; Catherine J Evans; Gunn Grande; Chris Todd; Massimo Costantini; Fliss E Murtagh; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2020-09-30

8.  Quality of life and added value of a tailored palliative care intervention in patients with soft tissue sarcoma undergoing treatment with trabectedin: a multicentre, cluster-randomised trial within the German Interdisciplinary Sarcoma Group (GISG).

Authors:  Leopold Hentschel; Stephan Richter; Hans-Georg Kopp; Bernd Kasper; Annegret Kunitz; Viktor Grünwald; Torsten Kessler; Jens Marcus Chemnitz; Uwe Pelzer; Ulrich Schuler; Janet Freitag; Andrea Schilling; Beate Hornemann; Karin Arndt; Martin Bornhäuser; Markus Kajo Schuler
Journal:  BMJ Open       Date:  2020-08-27       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.